Two-component peptide reference blend
CJC-1295 + Ipamorelin 5 mg / 5 mg
CJC-1295 and Ipamorelin research blend supplied in equal labeled quantities for qualified laboratory research.
Scientific background
CJC-1295 is a synthetic analog of growth hormone-releasing hormone, while ipamorelin is a growth hormone secretagogue that acts through the ghrelin receptor. This exact research blend is not an FDA-approved medicine. Published human data are limited, and FDA has identified safety and characterization concerns for compounded CJC-1295 and ipamorelin products.
In plain language
These two research peptides are studied for how they signal the body's growth-hormone system. They are not approved as this combination for treating people, and there is not enough evidence to call the blend safe for personal use.